Nuclear Receptor Assay Applications Presented Fall 2009
Click the icon in the upper left hand corner to view speaker notes for slides.
Have a question? Ask a Scientist
GloResponse is a trademark and Dual-Luciferase is a registered trademark of Promega Corporation. HighWire Press is a registered trademark of the Board of Trustees of the Leland Stanford Junior University
©2009, Promega Corporation. All rights reserved. Application Overview
POST-TRANSCRIPTION MIRNA CONTROL In vivo PROTEIN applications INTERACTIONS
expression level varies with treatment NUCLEAR RECEPTORS
SIGNALING Experimental firefly luciferase PATHWAY construct expression level varies little with PROMOTER treatment Control DISSECTION Renilla luciferase construct
2 Traditional Nuclear Receptor Assays
Steroid A good assay Works with endogenous receptors
Steroid Receptor
RNA Pol II NRE luciferase
3 Your expression analysis found an uncharacterized NR…
N-Terminal Hinge C-Terminal Domain Region Domain A/B C D E F DNA Binding Ligand Binding Domain Domain
•Response elements are not specifically known •Agonists are not known •Coactivators are not known •How can you do work on this nuclear receptor?
A One-Hybrid Luciferase Reporter Assay can help understand the nuclear receptor more fully
4 Universal Nuclear Receptor Assays
Ligand binding domain responsible for: • homodimerization (class I receptors) • heterodimerization (class II receptors) • corepressor binding • coactivator binding
Nuclear Receptor Ligand Binding Domain
pBIND Vector GAL4 BD
GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 TATA UAS UAS UAS UAS UAS UAS UAS UAS UAS Box luc2P pGL4.35[luc2P/9XGAL4UAS/Hygro] Vector
5 What you need…
GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 GAL4 TATA UAS UAS UAS UAS UAS UAS UAS UAS UAS Box luc2P pGL4.35[luc2P/9XGAL4UAS/Hygro] Vector
Nuclear Receptor Ligand Binding Domain
Both vectors ready to make stable cells • pGL4.35 Æ HygR • pFN26A Æ NeoR
6 Nuclear Receptor Assay Principle
1 TRANSFECT 2 CULTURE 2-3 DAYS
3 TREAT
DUAL-LUCIFERASE® 4 ASSAY pGL4.35 Perform mutagenesis on the ligand binding domain and assay in your responsive cell. pBIND • No interference from Screen for endogenous receptor agonists, antagonists, Make your own co-activators, Nuclear Receptor co-repressors Luciferase Reporter Cell line • pGL4.35 HygR
7 Pre-designed tools available for nuclear receptor assays
Pre-designed Estrogen Receptor α–& Glucocorticoid Receptor– GAL4 Binding Domain fusions available
GloResponse™ 9XGAL4UAS-luc2P HEK293 Cell Line
HEK 293 HygR cell line made with pGL4.35
Ready to use with the nuclear receptor or CheckMate™ Assays
8 Case Study: Coactivator of Vitamin D receptor
Vitamin D receptor (VDR) is a nuclear receptor that upon ligand binding displaces a co-repressor and allows co-activators to bind, allowing transcription. Central question: • Peroxisome Proliferator-Activated Receptor γ coactivator-1 α (PGC- 1α) and the Vitamin D receptor have overlapping tissue distribution, • Does PGC1α function as a coactivator of VDR?
Savkur, R.S., et al. (2005) Mol. Pharmacol. 68, 511-517.
9 Case Study: Savkur, R.S. et al. PGC-1α is a coactivator of VDR
Hinge AF-2 Region (Helix 12) GAL4 Binding Domain D E F
Vitamin D3 Binding Domain
Fold Increase Luc
Constructs DMSO VitD3 activity +– 1 Gal4BD-VDR + pG5-luc pG5-luc –+ 5
+– 1 Gal4BD-VDR + PGC-1α Gal4BD- + pG5-luc up to –+ PGC-1α VDR 500 +– 1 Gal4BD-VDR(ΔAF-2) + PGC-1α + pG5-luc –+ 1
Conclusions supported by work with full receptor & mammalian two-hybrid work
10 More Information…
Go to Go to Go to Go to pGL4.35 pBIND-ERα pBIND-GR cell line Product Product Product Technical Protocol Protocol Protocol Manual
Paguio, A., et al. (2008) Improvements to luciferase reporter assays for nuclear receptor function. PS065 presented at Society for Biomolecular Sciences meeting.
11